Prostate Cancer
A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma.
September 25, 2023
Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers.
September 25, 2023
Alterations in the Epigenetic Machinery Associated with Prostate Cancer Health Disparities.
September 25, 2023
LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function.
September 25, 2023
Fifteen-Year Outcomes of the ProtecT Trial for Localized Prostate Cancer.
September 25, 2023
Germline DNA Repair Genes Pathogenic Variants Among Mexican Patients With Prostate Cancer.
September 25, 2023
Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses.
September 25, 2023
A polygenic two-hit hypothesis for prostate cancer.
September 25, 2023
A Transgender Patient with Prostate Cancer: Lessons Learnt.
September 25, 2023
Aggressive Prostate Cancer Is Preventable and so Are Racial Disparities.
September 25, 2023
Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis.
September 25, 2023
Racism Might Cause Prostate Cancer and Definitely Causes Excess Unemployment, Lost Wages, and Excess Cancer Deaths.
September 25, 2023
Evaluation of CD47 in the Suppressive Tumor Microenvironment and Immunotherapy in Prostate Cancer.
September 25, 2023
Barriers to and facilitators of prostate cancer screening among men in Uganda prisons.
September 25, 2023
Risk Modeling for Individualization of the FLAME Focal Boost Approach in External Beam Radiation Therapy for Patients With Localized Prostate Cancer.
September 22, 2023